J.P. Droz

836 total citations
26 papers, 216 citations indexed

About

J.P. Droz is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J.P. Droz has authored 26 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in J.P. Droz's work include Testicular diseases and treatments (12 papers), Neuroblastoma Research and Treatments (7 papers) and Sarcoma Diagnosis and Treatment (7 papers). J.P. Droz is often cited by papers focused on Testicular diseases and treatments (12 papers), Neuroblastoma Research and Treatments (7 papers) and Sarcoma Diagnosis and Treatment (7 papers). J.P. Droz collaborates with scholars based in France, Netherlands and Belgium. J.P. Droz's co-authors include Stéphane Culine, Stéphane Culine, Joseph Kattan, Catherine Lhommé, P. Wibault, Pierre Duvillard, Pierre Biron, Guy Michel, A. Kramar and Christine Haie‐Méder and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

J.P. Droz

24 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Droz France 9 152 70 42 41 40 26 216
Wendy Ansell United Kingdom 11 155 1.0× 165 2.4× 41 1.0× 43 1.0× 67 1.7× 23 304
Jan Wolter Oosterhuis Netherlands 9 171 1.1× 92 1.3× 37 0.9× 16 0.4× 66 1.6× 22 287
L. Baggerman Netherlands 6 207 1.4× 76 1.1× 110 2.6× 36 0.9× 51 1.3× 7 291
Yoji Wani Japan 12 103 0.7× 72 1.0× 83 2.0× 19 0.5× 48 1.2× 34 323
Timothy Christmas United Kingdom 10 148 1.0× 168 2.4× 22 0.5× 16 0.4× 96 2.4× 18 282
S. Gonzalez France 7 180 1.2× 19 0.3× 45 1.1× 16 0.4× 26 0.7× 14 290
R. Bastús Spain 9 397 2.6× 133 1.9× 43 1.0× 61 1.5× 79 2.0× 22 462
A. Greist United States 7 189 1.2× 46 0.7× 73 1.7× 56 1.4× 62 1.6× 10 445
D. Yu. Kachanov Russia 9 70 0.5× 39 0.6× 9 0.2× 49 1.2× 60 1.5× 93 224
Jessica D. Lubahn United States 10 159 1.0× 190 2.7× 12 0.3× 27 0.7× 107 2.7× 10 345

Countries citing papers authored by J.P. Droz

Since Specialization
Citations

This map shows the geographic impact of J.P. Droz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Droz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Droz more than expected).

Fields of papers citing papers by J.P. Droz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Droz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Droz. The network helps show where J.P. Droz may publish in the future.

Co-authorship network of co-authors of J.P. Droz

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Droz. A scholar is included among the top collaborators of J.P. Droz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Droz. J.P. Droz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fléchon, Aude, Stéphane Culine, C Théodore, & J.P. Droz. (2005). Pattern of Relapse after First Line Treatment of Advanced Stage Germ-Cell Tumors. European Urology. 48(6). 957–964. 14 indexed citations
2.
Bono, Johann S. de, Joaquim Bellmunt, J.P. Droz, et al.. (2005). An open label, phase II, multicenter, study to evaluate the efficacy and safety of pertuzumab (P) in chemotherapy naïve patients (pts) with hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 23(16_suppl). 4609–4609. 6 indexed citations
3.
Fléchon, Aude, Emmanuelle Tavernier, Pierre Meeus, Michel Rivoire, & J.P. Droz. (2004). Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): impact on outcome. Journal of Clinical Oncology. 22(14_suppl). 4584–4584. 1 indexed citations
4.
André, Fabrice, Karim Fizazi, Stéphane Culine, et al.. (2000). Peritoneal Carcinomatosis in Germ-Cell Tumor. American Journal of Clinical Oncology. 23(5). 460–462. 4 indexed citations
5.
Schrijvers, D., G. Catimel, Martin Highley, et al.. (1999). KW-2149-induced pulmonary toxicity is not prevented by corticosteroids. Anti-Cancer Drugs. 10(7). 633–640. 7 indexed citations
6.
Zanetta, Sylvie, Aline Guillot, C Ardiet, et al.. (1999). A dose finding and pharmacokinetic study of docetaxel (TXT) and methotrexate (MTX) in patients with epithelial cancer. European Journal of Cancer. 35. S288–S288. 2 indexed citations
7.
Lhommé, Catherine, et al.. (1997). Cisplatin-Based Chemotherapy in the Management of Germ Cell Tumors of the Ovary: The Institut Gustave Roussy Experience. Gynecologic Oncology. 64(1). 160–165. 16 indexed citations
8.
9.
Culine, Stéphane & J.P. Droz. (1996). Primary treatment in stage ii non-seminomatous germ cell tumours of the testis: a matter of scalpel or drug infusion?. European Journal of Cancer. 32(10). 1641–1644. 9 indexed citations
10.
Droz, J.P., Stéphane Culine, Pierre Biron, & A. Kramar. (1996). High-dose chemotherapy in germ-cell tumors. Annals of Oncology. 7(10). 997–1003. 22 indexed citations
11.
Culine, Stéphane, Catherine Lhommé, Joseph Kattan, et al.. (1995). Cisplatin-Based Chemotherapy in Dysgerminoma of the Ovary: Thirteen-Year Experience at the Institut Gustave Roussy. Gynecologic Oncology. 58(3). 344–348. 20 indexed citations
12.
Kattan, Joseph, Stéphane Culine, Christine Théodore, & J.P. Droz. (1995). Phase II Trial of Ifosfamide, Fluorouracil, and Folinic Acid (FIFO Regimen) in Relapsed and Refractory Urothelial Cancer. Cancer Investigation. 13(3). 276–279. 5 indexed citations
13.
Catimel, G. & J.P. Droz. (1995). [Future trends in chemotherapy and impact on the management of emesis].. PubMed. 82(12). 1067–71. 1 indexed citations
14.
Ostronoff, M, Carole Soussain, Angel Moran, et al.. (1995). Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases.. PubMed. 37(5). 267–72. 8 indexed citations
15.
Culine, Stéphane, J.P. Droz, Élie Fadel, et al.. (1993). Penile cancer chemotherapy: Twelve years' experience at Institut Gustave-Roussy. Urology. 42(5). 559–562. 36 indexed citations
16.
Culine, Stéphane, et al.. (1993). Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy. Annals of Oncology. 4(10). 871–875. 17 indexed citations
17.
Fosså, Sophie D., et al.. (1992). Vinblastine in metastatic renal cell carcinoma: EORTC phase II Trial 30882. European Journal of Cancer. 28(4-5). 878–880. 21 indexed citations
18.
Stoter, G., George J. Bosl, J.P. Droz, et al.. (1990). Prognostic factors in metastatic germ cell tumors.. PubMed. 357. 313–9. 6 indexed citations
19.
Rougier, P, P Lasser, Dominique Elias, et al.. (1989). Intra-Arterial Hepatic Chemotherapy for Metastatic Liver from Colo-Rectal Carcinoma Origin. PubMed. 5(1). 47–54. 4 indexed citations
20.
Lasser, P, et al.. (1986). [Isolated hepatic metastases. Treatment by intra-arterial chemotherapy using a subcutaneous access chamber].. PubMed. 15(6). 237–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Ansell Breakdown of academic impact, for papers by Jan Wolter Oosterhuis Breakdown of academic impact, for papers by L. Baggerman Breakdown of academic impact, for papers by Yoji Wani Breakdown of academic impact, for papers by Timothy Christmas Breakdown of academic impact, for papers by S. Gonzalez Breakdown of academic impact, for papers by R. Bastús Breakdown of academic impact, for papers by A. Greist Breakdown of academic impact, for papers by D. Yu. Kachanov Breakdown of academic impact, for papers by Jessica D. Lubahn
Rankless by CCL
2026